Maria Karlou

About Maria Karlou

To address the challenges of resistance to therapy and cancer progression in CRPC patients, it is important to study the underlying mechanisms. Dr. Maria Karlou proposes to address these challenges by studying cancer progression in mouse models and cell-based models of human prostate cancer. These studies will inform the design of better therapies for castration-resistant prostate cancer. Dr. Karlou is establishing a new Tissue Derivatives Laboratory at the University of Athens. She proposes to study mechanisms of resistance to therapy in castration-resistant prostate cancer patients which may improve treatment strategies for patients with advanced, castration-resistant prostate cancer.